An economic evaluation of lung transplantation

Journal of Thoracic and Cardiovascular Surgery

Volumn 123, Issue 3, 2002, Pages 411-420

  Anyanwu, Ani C ^a,b   McGuire, Alistair ^a,b   Rogers, Chris A ^a,b   Murday, A J ^a,b  

^a CITY UNIVERSITY   (United Kingdom)

^b ROYAL COLLEGE OF SURGEONS OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; HEALTH CARE COST; HEART LUNG TRANSPLANTATION; HUMAN; INTENSIVE CARE; INTERMETHOD COMPARISON; LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SURGICAL APPROACH; SURVIVAL RATE; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED KINGDOM;

EID: 0036521234     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2002.120342     Document Type: Article

References (30)

1. Buxton MJ. Economics of transplantation in the 21st century: new scientific opportunities but greater economic problems. Transplant Proc. 1997;29:2723-4.
2. Deng MC, De Meester JM, Smits JA, Heinecke J, Scheld HH. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. BMJ. 2000;321:540-5.
3. Eggers PW, Kucken LE. Cost issues in transplantation. Surg Clin North Am. 1994;74:1259-67.
4. Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation: a pilot study. University of Washington Medical Center Lung Transplant Study Group. Chest. 1995;108:1594-601.
5. Al MJ, Koopmanschap MA, van Enckevort PJ, Geertsma A, van der Bij W, de Boer WJ, et al. Cost-effectiveness of lung transplantation in The Netherlands: a scenario analysis. Chest. 1998;113:124-30.
6. Anyanwu AC, Rogers CA, Murday J. Where are we today with pulmonary transplantation? Current results from a national cohort. UK Cardiothoracic Transplant Audit Steering Group. Transpl Int. 2000;13 Suppl 1:S245-6.
7. van Enckevort PJ, Koopmanschap MA, TenVergert EM, Geertsma A, van der Bij W, de Boer WJ, et al. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ. 1997;6:479-89.
8. Geertsma A, TenVergert E, Bonsel GJ, de Boer W, van der Bij W. Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant. 1998;17:511-6.
9. van Enckovert PJ, TenVergert EM, Bonsel GJ, Geertsma A, van-der BW, de BW et al. Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care. 1998;14:344-56.
10. Anyanwu AC, McGuire A, Rogers CA, Murday AJ. Assessment of quality of life in lung transplantation using a simple generic tool. Thorax. 2001;56:218-22.
11. EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
12. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53-72.
13. Sharples LD, Taylor GJ, Karnon J, Caine N, Buxton M, McNeil K, et al. A model for analyzing the cost of the main clinical events after lung transplantation. J Heart Lung Transplant. 2001;20:474-82.
14. Hardy JD, Webb WR, Dalton ML. Lung homotransplantation in man: report of the initial case. JAMA. 1963;157:707-13.
15. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med. 1986;314:1140-5.
16. Gartner SH, Sevick MA, Keenan RJ, Chen GJ. Cost-utility of lung transplantation: a pilot study. J Heart Lung Transplant. 1997;16:1129-34.
17. Michel BC, Van Hout BA, Bonsel GJ. Assessing the benefits of transplant services. Baillieres Clin Gastroenterol. 1994;8:411-23.
18. Rice DP. Cost-of-illness studies: fact or fiction? Lancet. 1998;344:1519-20.
19. Paris W, Woodbury A, Thompson S, Levick M, Nothegger S, Arbuckle P, et al. Returning to work after heart transplantation. J Heart Lung Transplant. 1993;12:46-53.
20. Rosenblum DS, Rosen ML, Pine ZM, Rosen SH, Borg Stein J. Health status and quality of life following cardiac transplantation. Arch Phys Med Rehabil. 1993;74:490-3.
21. Gross CR, Raghu G. The cost of lung transplantation and the quality of life post-transplant. Clin Chest Med. 1997;18:391-403.
22. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report - 1997. J Heart Lung Transplant. 1997;16:691-712.
23. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report - 2000. J Heart Lung Transplant. 2000;19:909-31.
24. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet. 1998;351:24-7.
25. Bonsel GJ, Klompmaker IJ, Essink BM, Habbema JD, Slooff MJ. Cost-effectiveness analysis of the Dutch liver transplantation programme. Transplant Proc. 1990;22:1481-4.
26. Mannes GP, de Boer WJ, van der Bij W, Grevink RG, Koeter GH. Three hundred patients referred for lung transplantation: experiences of the Dutch Lung Transplantation Program. Groningen Lung Transplantation Group. Chest. 1996;109:408-13.
27. Dark JH. Priorities for lung transplantation. Lancet. 1998;351:4-5.
28. Anyanwu AC, Rogers CA, Murday AJ. Does splitting the lung block into two single lung grafts equate to doubling the societal benefit from bilateral lung donors? Comparisons between two single versus one bilateral lung transplant. UK Cardiothoracic Transplant Audit Steering Group. Transpl Int. 2000; 13 Suppl 1:S201-2.
29. Evans RW, Manninen DL, Dong FB. An economic analysis of heart-lung transplantation: costs, insurance coverage, and reimbursement. J Thorac Cardiovasc Surg. 1993;105:972-8.
30. Hogness JR, Van Antwerp M. the artificial heart: prototypes, policies, and patients. Washington, DC: National Academy Press; 1991.